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Apoptosis-related genes play important roles in thymocyte maturation. We show that 
cellular FLICE-like inhibitory protein (c-FLIP), a procaspase-8–like apoptotic regulator, plays 
an essential role in the efficient development of mature T lymphocytes. Mice conditionally 
lacking c-FLIP in T lymphocytes display severe defects in the development of mature T cells, 
as indicated by a dramatically reduced number of CD4
 
 
 
 and CD8
 
 
 
 T cells in the spleen and 
lymph nodes of mutant mice. The impaired T lymphocyte maturation in c-FLIP conditional 
knockout mice occurs at the single-positive thymocyte stage and may be caused by 
enhanced apoptosis in vivo. Moreover, although c-FLIP has been implicated in T cell receptor 
signaling through nuclear factor (NF)-
 
 
 
B and Erk pathways, activation of NF-
 
 
 
B and Erk in 
c-FLIP–deficient thymocytes appears largely intact. Collectively, our data suggest that the 
primary role of c-FLIP in thymocyte maturation is to protect cells from apoptosis.
 
T lymphocyte development is tightly regulated
by a plethora of signaling molecules and can be
divided into distinct stages (for reviews see refer-
ences 1–3). CD4
 
 
 
CD8
 
 
 
 double-negative (DN)
thymocytes represent the first step of thymocyte
maturation. Upon TCR
 
 
 
 rearrangement and
 
 
 
-selection, DN cells proliferate and become
CD4
 
 
 
CD8
 
 
 
 double positive (DP). DP thy-
mocytes account for a majority of cells in the
thymus. These cells rearrange 
 
TCR
 
 
 
 genes and
undergo a strict positive and negative selection
process. DP thymocytes expressing an interme-
diate affinity for self-peptide/MHC are selected
for further maturation and become either CD4
 
 
 
or CD8
 
 
 
 single-positive (SP) thymocytes. SP
thymocytes may undergo further functional
maturation either within the thymus or after
exit to the periphery.
The TNF family member Fas and its ligand
FasL may regulate thymocyte maturation. Fas is
expressed by DP, as well as CD4
 
 
 
 and CD8
 
 
 
SP, but not DN thymocytes (4–7). FasL is de-
tected in thymic stromal cells and in a fraction
of thymocytes (8, 9). Several studies have impli-
cated Fas and FasL in thymocyte maturation.
For example, Fas has been shown to have a role
in negatively selecting certain subsets of thy-
mocytes (10, 11). FasL plays an important role
in the selection of thymocyte subsets expressing
moderate TCR affinity by signaling through
itself (9). Although both Fas and FasL are ex-
pressed throughout the thymus, and DP thy-
mocytes are sensitive to FasL-induced apoptosis,
Fas-mediated thymocyte apoptosis does not
appear to prevail in the thymus (12). This lim-
ited role of Fas in thymocyte apoptosis must be
regulated by active mechanisms that prevent Fas
signaling. One way to achieve this is by inhibit-
ing the Fas-induced death signaling pathway
through an apoptosis inhibitor named cellular
FLICE-like inhibitory protein (c-FLIP).
c-FLIP (also called Casper, I-FLICE, CASH,
FLAME-1, MRIT, CLARP, and usurpin) is a
procaspase-8–like protein (13–20). Two isoforms
of c-FLIP (c-FLIP
 
L
 
 and c-FLIP
 
S
 
) derived from
alternative splicing have been identified. c-FLIP
 
L
 
contains two tandem death effector domains at
the amino terminus and a catalytically inactive
caspase-like domain at the carboxy terminus.
cFLIP
 
S
 
 has only two death effector domains.
Both isoforms of c-FLIP interact with an adaptor
protein, Fas-associated death domain, and are re-
cruited to the death-inducing signaling complex.
The major function of c-FLIP in regulating
apoptosis is to inhibit Fas-mediated caspase-8 ac-
tivation (21). However, when expressed at a low
concentration, c-FLIP
 
L
 
 can act as an activator of
procaspase-8 (22).
Additional studies also suggest that c-FLIP
may be involved in T lymphocyte activation
and proliferation (23), and transgenic expression
of c-FLIP
 
L
 
 in T cells results in increased CD3-
induced proliferation (24). Furthermore, over-
expression of c-FLIP in Jurkat T cells promotes
activation of NF-
 
 
 
B and Erk signaling path-
ways (25). Nevertheless, the role of c-FLIP in T
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lymphocyte development and function has not been investi-
gated in T cells lacking c-FLIP expression because c-FLIP–
deficient mice die during embryogenesis (26).
To examine whether c-FLIP regulates T lymphocyte
maturation, we generated c-FLIP conditional KO mice. T
lineage–specific deletion of c-FLIP impairs thymocyte devel-
opment at the CD4
 
 
 
 and CD8
 
 
 
 SP stage and results in se-
verely reduced numbers of mature CD4
 
 
 
 and CD8
 
 
 
 T lym-
phocytes in the spleen and LN. c-FLIP
 
 
 
/
 
 
 
 thymocytes
exhibit enhanced sensitivity to TCR/CD3 and Fas-induced
killing. Furthermore, freshly isolated CD4
 
 
 
 and CD8
 
 
 
 thy-
mocytes from c-FLIP
 
 
 
/
 
 
 
 mice display a higher rate of apop-
tosis than wild-type cells. Interestingly, activation of NF-
 
 
 
B
and Erk pathways is largely intact in c-FLIP–deficient T lym-
phocytes. Collectively, our results demonstrate an essential
role for c-FLIP in the development of mature T lymphocytes.
 
RESULTS
Generation of c-FLIP conditional KO mice
 
To generate mice specifically lacking c-FLIP in T lympho-
cytes, we constructed a targeting vector with exon 1 encod-
ing amino acids 1–98 of c-FLIP, flanked with two 
 
loxP
 
 sites
(Fig. 1 A). The flanked exon is used by both c-FLIP
 
L
 
 and
c-FLIP
 
S
 
. A neomycin-resistant gene cassette located within
the two 
 
loxP
 
 sites was flanked by two 
 
FRT
 
 sites (Fig. 1 A).
We generated chimeric mice by microinjecting three cor-
rectly targeted embryonic stem (ES) cell clones (Fig. 1 B)
into C57BL/6 blastocysts. Male chimeric mice were bred
with FLPeR female mice to delete the neomycin cassette in
vivo. The c-FLIP floxed mice (c-FLIP
 
f/f
 
) were then bred
with Lck-cre transgenic mice to induce specific deletion of
this gene in T lymphocytes. Restriction analysis of genomic
DNA from total thymocytes of c-FLIP
 
f/f
 
Lck-cre (c-FLIP
 
 
 
/
 
 
 
)
and c-FLIP
 
f/
 
 
 
Lck-cre (c-FLIP
 
 
 
/
 
 
 
) mice revealed that floxed
c-FLIP exon 1 was deleted in 
 
 
 
98% of the thymocytes (Fig.
1 C). c-FLIP protein expression in the thymus of these mice
was also reduced 
 
 
 
98% (Fig. 1 D). These results indicate
that Lck-cre expression induced efficient deletion of c-FLIP
in developing thymocytes.
 
Thymocyte development in c-FLIP conditional KO mice
 
c-FLIP
 
 
 
/
 
 
 
 mice had normal growth and development. We
examined thymocyte development in 3–5-wk-old c-FLIP
 
 
 
/
 
 
 
and age-matched wild-type (c-FLIP
 
 
 
/
 
 
 
) mice. Total thy-
mocyte numbers in c-FLIP
 
 
 
/
 
 
 
 mice were not significantly
different from those in c-FLIP
 
 
 
/
 
 
 
 mice (KO, 263 
 
 
 
 99 
 
 
 
10
 
6
 
, 
 
n 
 
  
 
19; control, 312 
 
 
 
 94 
 
 
 
 10
 
6
 
, 
 
n 
 
  
 
21; P
 
   
 
0.126).
Thymocyte development was further analyzed by the ex-
pression of CD4 and CD8. c-FLIP
 
 
 
/
 
 
 
 thymocytes devel-
oped successfully from the DN to the DP stage (Fig. 2 A).
However, the percentages of CD4
 
 
 
 and CD8
 
 
 
 SP thy-
mocytes in c-FLIP
 
 
 
/
 
 
 
 mice were reduced by 50–70% when
compared with wild-type control cells (Fig. 2 A). Further-
more, these cells did not completely down-regulate their
coreceptors. The mean fluorescence intensity (MFI) of CD8
expression on c-FLIP
 
 
 
/
 
 
 
 CD4
 
 
 
 SP was higher than that of
control CD4
 
 
 
 SP (10.2 vs. 2.9), whereas the MFI of CD4
expression on c-FLIP
 
 
 
/
 
 
 
 CD8
 
 
 
 SP thymocytes was also
higher than that of control CD8
 
 
 
 SP (50.1 vs. 31.3; Fig. 2
A), indicating that these CD4
 
 
 
CD8
 
low
 
 and CD8
 
 
 
CD4
 
low
 
thymocytes are on their way to complete maturation (27).
Correlating with the incomplete down-regulation of core-
ceptors in CD4
 
 
 
 and CD8
 
 
 
 SP thymocytes in c-FLIP
 
 
 
/
 
 
 
mice, the expression of heat-stable antigen (CD24) on CD4
 
 
 
and CD8
 
 
 
 SP cells was not obviously down-regulated when
compared with control cells (Fig. 2 C and not depicted).
To determine whether the reduced number of CD4
 
 
 
and CD8
 
 
 
 SP thymocytes in c-FLIP
 
 
 
/
 
 
 
 mice was caused by
an impaired positive selection of DP thymocytes, we exam-
ined the expression of CD3, CD69, and CD5 on c-FLIP
 
 
 
/
 
 
 
DP thymocytes. Up-regulation of these surface molecules on
DP thymocytes occurs after successful positive selection. As
shown in Fig. 2 B, the expression of CD3, CD69, and CD5
was indistinguishable between c-FLIP
 
 
 
/
 
 
 
 and c-FLIP
 
 
 
/
 
 
 
 DP
cells, suggesting that thymocyte positive selection is not im-
paired in the absence of c-FLIP. We then determined the
expression of TCR on c-FLIP
 
 
 
/
 
 
 
 CD4
 
 
 
 and CD8
 
 
 
 SP thy-
Figure 1. Generation of c-FLIP conditional KO mice. (A) Diagram of 
the c-FLIP targeting construct and targeted alleles. E1–E4, exon 1–4 of the 
c-FLIP gene; SI, SacI; EI, EcoRI; L, loxP site; F, FRT site; DT, diptheria toxin; 
Neo, neomycin-resistant gene. The probe used in DNA blot analysis is indi-
cated. (B) Southern blot analysis of genomic DNA from targeted ES cells. 
Genomic DNA from targeted TC1 ES cells were digested with SacI and 
probed as indicated in A. (C) Southern blot analysis of genomic DNA from 
c-FLIP conditional KO mice. Total thymocyte DNA from c-FLIPf/fLck-cre and 
other control mice were digested with EcoRI and probed as in B. (D) Western 
blot analysis of c-FLIP protein expression in total thymocytes from c-FLIP /  
and c-FLIP /  mice. Loading control is a nonspecific band on the same blot. 
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mocytes. Both c-FLIP
 
 
 
/
 
 
 
 CD4
 
 
 
 and CD8
 
 
 
 SP thymocytes
expressed similar levels of surface TCR to those on control
cells (Fig. 2 C). However, the percentage of c-FLIP
 
 
 
/
 
 
 
CD8
 
 
 
CD3
 
 
 
 SP thymocytes was lower than that in the con-
trol cells (46.7% vs. 73.1%), indicating fewer mature CD8
 
 
 
SP and a relatively more immature SP thymocytes among
CD8
 
 
 
 thymocytes (Fig. 2 C).
We next examined the DN compartment in the c-FLIP
 
 
 
/
 
 
 
thymus. CD4
 
 
 
CD8
 
 
 
CD3
 
 
 
 triple negative thymocytes were
gated, and the expression of CD25 and CD44 was analyzed.
Pro–T cell development as defined by the expression of CD25
and CD44 was comparable in both c-FLIP
 
 
 
/
 
 
 
 and c-FLIP / 
mice (Fig. 2 D). However, when the expression of TCR  
and TCR   was assessed in the CD4 CD8  DN compart-
ment, we found that the percentage of TCR    DN thy-
mocytes in c-FLIP /  mice was reduced  90%, whereas the
percentage of TCR    DN thymocytes was slightly increased
(Fig. 2 E). Collectively, these results demonstrate that the de-
velopment of CD4  and CD8  SP thymocytes and TCR  
DN cells was impaired in c-FLIP /  mice.
Lack of mature T lymphocytes in c-FLIP /  mice
We first examined the peripheral T cell compartment in
3-wk-old c-FLIP /  mice. Strikingly, although control mice
had a filled peripheral T cell compartment, c-FLIP /  mice
essentially lacked peripheral CD4  and CD8  T lymphocytes
(Fig. 3 A). The numbers of CD4  and CD8  T cells in the
spleen and LN of c-FLIP /  mice were in the range of 0.1–
2% of those in control mice (Fig. 3 B). Because the lack of
mature T cells in c-FLIP /  mice may be caused by a delayed
filling of the peripheral lymphoid compartment, we exam-
ined the peripheral T cell compartment in 5–10-wk-old
mice. The percentages of CD4  and CD8  peripheral T
lymphocytes in 5–10-wk-old c-FLIP /  mice were higher
than those in 3-wk-old mutant mice but still dramatically
lower than those in age-matched controls (Fig. 3 A). Interest-
ingly, the few CD4  and CD8  T cells in c-FLIP /  mice
expressed higher levels of CD44 and lower levels of CD62L
(Fig. 3 C). In addition, when compared with controls, a
higher fraction of CD4  and CD8  mature T cells in
c-FLIP /  mice expressed the T cell activation markers
CD25 and CD69 (Fig. 3 C). Interestingly, TCR  expression
on both c-FLIP /  CD4  and CD8  peripheral T cells was
lower than that on control cells (Fig. 3 C). Notably, a fraction
of c-FLIP /  CD8  T cells were also TCR   (Fig. 3 C).
This CD8 TCR   population expressed CD11c and ac-
counted for 0.42% of the total splenocytes, compared with a
similar population in control spleen that accounted for 0.36%
of the total splenocytes. Therefore, these cells are splenic den-
dritic cells that are enriched because of the markedly lower
number of CD8  T cells in c-FLIP /  mice. Collectively,
these phenotypic characteristics suggest that a fraction of ma-
ture T cells in c-FLIP /  mice were undergoing active pro-
liferation. However, it remains to be determined whether all
these cells that represent mature T cells escaped Lck-Cre–
mediated deletion or cells differentiated in the c-FLIP–inde-
pendent pathway.
The age-related accumulation of CD4  and CD8  T
lymphocytes in the spleen and LN of c-FLIP /  mice raised
the possibilities that either these cells underwent maturation
independent of c-FLIP or these cells derived from a few cells
that escaped cre-mediated deletion in the thymus. To distin-
guish these possibilities, we purified CD4  and CD8  T
lymphocytes from the spleen and LN of c-FLIP /  mice by
double-FACS sorting and tested the deletion of c-FLIP alleles
in these cells. As shown in Fig. 3 D, the floxed c-FLIP allele
Figure 2. Thymocyte maturation in c-FLIP conditional KO mice. 
(A) FACS analysis of thymocytes from 3-wk-old c-FLIP /  and wild-type 
mice ( / ). The percentages of CD8 SP (top left), DP (top right), DN (bottom 
left), and CD4 SP (bottom right) cells are shown. (B) Histograms of CD3, 
CD69, and CD5 expression on CD4 CD8  DP thymocytes from c-FLIP /  
and control mice. (C) CD3 and CD24 expression on CD8  or CD4  SP thy-
mocytes of c-FLIP /  and control mice. (D) Development of pro–T cells in 
c-FLIP /  mice. CD3 CD4 CD8  triple-negative thymocytes were analyzed 
for the expression of CD44 (top) and CD25 (right). (E) Expression of TCR   
and TCR   in the CD4 CD8  DN compartment of c-FLIP /  mice. DN 
thymocytes were analyzed for the expression of TCR   and TCR  . The 
percentages of total DN thymocytes are shown. The horizontal lines in 
B, C, and E indicate the flow cytometry analysis gates and mark the 
respective cell populations.C-FLIP IN MATURE T CELL DEVELOPMENT | Zhang and He 398
Figure 3. Lack of mature T cells in c-FLIP conditional KO mice. 
(A) FACS analyses of CD4 and CD8 expression in the spleen and LN of 3- or 
5-wk-old c-FLIP /  and control mice. The percentages of CD4  or CD8  
mature T cells in these lymphoid organs are shown. (B) Total cell numbers 
of CD4  and CD8  T cells in c-FLIP /  and age- and sex- matched control 
mice that were 3–5-wk old. (C) FACS analyses of surface molecule expression 
on CD4  and CD8  T cells from c-FLIP /  and control mice (8-wk old). 
Numbers for CD25, CD69, CD62L, and CD44 staining represent the per-JEM VOL. 202, August 1, 2005 399
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was readily detected in the sorted CD4  peripheral T cells
from c-FLIP /  mice, indicating that c-FLIP allele deletion
was incomplete in at least some of these cells. In contrast, we
did not detect the floxed c-FLIP allele from total thymocytes
of c-FLIP /  mice under this PCR condition, suggesting a
high deletion efficiency of the c-FLIP allele in the thymus.
Collectively, our results demonstrate that c-FLIP is essential
for the efficient development of mature T lymphocytes.
Enhanced apoptosis to TCR/CD3 and Fas stimulation 
in thymocytes from c-FLIP /  mice
The lack of mature T lymphocytes in c-FLIP /  mice may re-
sult from impaired survival and/or expansion of these cells.
Given the extensive evidence showing that c-FLIP modulates
TCR signaling, we examined thymocyte proliferation after
TCR-mediated stimulation. Total thymocytes from c-FLIP / 
and control mice were labeled with carboxyfluorescein diace-
tate succinimidyl ester (CFSE) and stimulated with plate-bound
CD3 for 4 d. The proliferation of CD4  and CD8  SP thy-
mocytes was determined by a FACS analysis of CFSE dilution
after gating on 7-amino-actinomycin D (7-AAD) Annexin V 
live cells. As expected, wild-type CD4  and CD8  SP but not
DP thymocytes proliferated extensively 4 d after stimulation
(Fig. 4 A). In contrast, we did not observe any noticeable num-
ber of CD4  or CD8  SP thymocytes from c-FLIP /  mice
with diluted CFSE labeling (Fig. 4 A). The lack of CFSElow cells
in the c-FLIP /  thymocyte culture is further supported by a
lack of IL-2 production in the culture stimulated either by anti-
CD3 or anti-CD3 plus anti-CD28 (Fig. 4 B). An identical re-
sult was seen when c-FLIP /  SP thymocytes were stimulated
by PMA plus ionomycin, which activates T cells by circum-
venting surface TCR (unpublished data).
The lack of proliferating c-FLIP /  SP thymocytes may
reflect a defect in TCR-mediated activation in these cells.
We then examined CD25 up-regulation on SP thymocytes
after anti-CD3 plus anti-CD28 stimulation. Unlike periph-
eral T cells, up-regulation of CD25 in wild-type SP thy-
mocytes was at a minimal level after a short period ( 10 h)
of stimulation and at a modest level after 24 h of stimulation
(unpublished data). We therefore stimulated SP thymocytes
for 48 h and analyzed CD25 expression on 7-AAD Annexin
V  live cells. As shown in Fig. 4 C, 48 h of stimulation by
anti-CD3/CD28 resulted in the expression of CD25 on 58%
of wild-type CD4  SP thymocytes. However, no increase of
CD25 expression in c-FLIP /  CD4  SP thymocytes was
observed. A similar defect was observed for CD25  expres-
sion on c-FLIP /  CD8  SP thymocytes and for CD69 up-
regulation on c-FLIP /  SP cells (unpublished data).
We considered two possibilities for the absence of CD25 
and CD69  c-FLIP /  CD4  SP thymocytes after anti-CD3/
CD28 stimulation. First, c-FLIP might be essential for TCR-
mediated activation, and impaired TCR signaling results in a
complete lack of activation and proliferation in c-FLIP /  SP
thymocytes. Second, TCR signaling may not be impaired in
c-FLIP /  thymocytes. Instead, activated SP thymocytes un-
dergo rapid cell death caused by a lack of protection by c-FLIP,
whereas unactivated thymocytes survive. The observation that a
fraction of wild-type CD4  (59%) and CD8  (28.8%) SP thy-
mocytes remained CFSEhigh after anti-CD3 stimulation (Fig. 4
A) suggests that these cells did not receive sufficient activating
signals from plate-bound anti-CD3. This further suggests that
the CFSEhigh c-FLIP /  CD4  and CD8  SP thymocytes (Fig.
4 A) represent cells that did not receive sufficient activating sig-
nals and, therefore, survived. To directly examine the effect of
TCR/CD3 signaling on c-FLIP /  thymocytes, we stimulated
FACS-sorted CD4  SP thymocytes with plate-bound anti-
CD3 and examined the apoptosis of these cells at different time
points. Anti-CD3 stimulation for as short as 2 h resulted in apop-
tosis of  40% of c-FLIP /  CD4  thymocytes, whereas only
12% of control cells were apoptotic (Fig. 5 A). Furthermore,
 80% of c-FLIP /  CD4  thymocytes underwent apoptosis
by 18 h of stimulation, whereas the apoptosis rate for control
Figure 4. Anti-CD3–induced proliferation and activation of c-FLIP /  
thymocytes. (A) Proliferation of thymocytes from c-FLIP /  and control 
mice. CFSE-labeled thymocytes were stimulated with plate-bound anti-CD3 
and anti-CD28 for 4 d, and the proliferation was analyzed by four-color 
FACS. The percentages of proliferative cells are shown. (B) IL-2 production 
by thymocytes from c-FLIP /  and control mice. Purified CD4  SP thy-
mocytes were stimulated with plate-bound antibodies as indicated and 
measured for IL-2 production with ELISA. (C) Expression of CD25 on CD4  
SP thymocytes after anti-CD3 and anti-CD28 stimulation. Thymocytes 
were stimulated with plate-bound anti-CD3/CD28 for 2 d, and CD4  SP 
thymocytes were analyzed for the expression of CD25.
centages of gated cells. Numbers for TCR  staining are MFI of all cells in 
each file. (D) PCR analysis of floxed c-FLIP allele in CD4  T cells from the 
spleen of c-FLIP /  mice as described in Materials and methods. Thy-
mocytes from c-FLIPf/ , c-FLIP / , and wild-type mice serve as controls. 
Bcl-2 functions as a PCR template loading control.C-FLIP IN MATURE T CELL DEVELOPMENT | Zhang and He 400
cells remained relatively constant (Fig. 5 A). These results dem-
onstrate that anti-CD3 stimulation of c-FLIP /  SP thymocytes
induced rapid cell death instead of proliferation as in the case for
wild-type CD4  T cells.
Given the role of c-FLIP in inhibiting caspase-8 activation,
the increased apoptosis in c-FLIP /  SP thymocytes to TCR/
CD3 stimulation may be caused by their enhanced sensitivity to
Fas-mediated killing. To test this, we incubated total thy-
mocytes from c-FLIP /  and wild-type mice with plate-bound
anti-Fas for 5 h and examined apoptotic cells using Annexin V
staining. Strikingly, 5 h of anti-Fas treatment induced a majority
(85–95%) of c-FLIP /  CD4  and CD8  SP to undergo apop-
tosis as compared with only a small fraction (25–30%) of control
cells (Fig. 5 B). Interestingly, c-FLIP /  DP thymocytes also
exhibited similarly high sensitivity to Fas-induced killing (Fig. 5
B). It was reported that anti-Fas antibody induces selective kill-
ing of DP thymocytes after a 16-h stimulation (4). We observed
only  45% of wild-type DP cells positive for Annexin V after
5 h of treatment (Fig. 5 B). However, treatment of thymocytes
with anti-Fas antibody for 16 h resulted in  99% cell death in
c-FLIP /  DP and CD4  and CD8  SP thymocytes, and
 99% cell death in wild-type DP thymocytes, but only  30%
cell death in wild-type CD4  and CD8  SP thymocytes (un-
published data). These results are in agreement with previous
data (4) and suggest that c-FLIP regulates the sensitivity of DP
and CD4  and CD8  SP thymocytes to TCR/CD3 and Fas-
induced apoptosis.
Enhanced apoptosis in freshly isolated SP thymocytes 
from c-FLIP /  mice
The fact that the DP compartment in c-FLIP /  mice is normal
even though these cells are just as sensitive as CD4  and CD8 
SP c-FLIP /  thymocytes to Fas-induced death in vitro (Fig. 5
B) suggests that DP and SP thymocytes may have received dif-
ferent levels of Fas signaling in vivo. If this is the case, c-FLIP / 
SP thymocytes may exhibit a higher rate of apoptosis than
controls without stimulation. We examined apoptosis in freshly
isolated thymocytes from c-FLIP /  and wild-type mice by
Annexin V staining. We detected small fractions of apoptotic
DP and SP thymocytes from wild-type mice (Fig. 6 A).
Whereas we observed three- to fourfold increases of apoptotic
cells in c-FLIP /  CD4  and CD8  SP thymocytes over the
control cells, there was no such increase for c-FLIP /  DP cells
(Fig. 6 A). Interestingly, when c-FLIP /  thymocytes were cul-
tured in vitro for 5 h without any stimulation, a dramatic in-
crease in the apoptosis of DP, as well as CD4  and CD8  SP,
thymocytes was observed (Fig. 6 B). To determine whether the
enhanced apoptosis is caused by altered Fas expression, we ex-
Figure 5. Enhanced apoptosis to TCR/CD3 and Fas stimulation by 
c-FLIP /  thymocytes. (A) Percentages of surviving cells after anti-CD3 
stimulation. FACS-sorted CD4  SP thymocytes from c-FLIP /  and control 
mice were stimulated with 5  g/ml of plate-bound anti-CD3 for the indi-
cated time and analyzed for apoptosis by 7-AAD and Annexin V staining. 
The percentages of 7-AAD Annexin V  cells are shown. (B) Percentages of 
apoptotic cells after anti-Fas stimulation for 5 h. Total thymocytes from 
c-FLIP /  and control mice were stimulated with 5  g/ml of plate-bound 
anti-Fas for 5 h, and the apoptosis was analyzed by four-color staining of 
CD4, CD8, 7-AAD, and Annexin V. The percentages of Annexin V  cells 
among each thymocyte subset are shown. Values are mean   SD.
Figure 6. Enhanced apoptosis of freshly isolated c-FLIP /  thy-
mocytes. (A) Percentages of apoptotic cells in freshly isolated c-FLIP /  
and control thymocytes. Freshly isolated thymocytes were stained with 
anti-CD4, CD8, and Annexin V. Annexin V  cells in each subset are shown. 
Data represent five mice in each group and are representative of three 
independent experiments. (B) Percentages of apoptotic cells in c-FLIP /  
and control thymocytes cultured for 5 h (n   3). Values shown are mean   
SD. (C) Fas expression on c-FLIP /  and control thymocytes. Numbers
are MFI. (D) Semiquantitative RT-PCR analysis of c-FLIPL in developing 
T lymphocytes. RNA from FACS-sorted T lymphocyte subsets at different 
developing stages were analyzed for the expression of c-FLIPL. Samples are 
in 1:5 serial dilution. Hypoxanthine phosphoribosyltransferase (HPRT) 
serves as a template quantity control.JEM VOL. 202, August 1, 2005 401
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amined Fas expression on these cells. Fas expression on
c-FLIP /  DN, DP, and CD4  SP thymocytes was compara-
ble to that on control cells (Fig. 6 C). The lower level of Fas ex-
pression on c-FLIP /  CD8  SP thymocytes may reflect an in-
creased proportion of immature SP thymocytes in this subset
(Fig. 6 C). Collectively, these results demonstrate elevated
apoptosis in freshly isolated c-FLIP /  SP thymocytes.
To better explain the defective thymocyte development in
c-FLIP /  mice, we examined c-FLIP expression in develop-
ing T lymphocytes. Total RNA from FACS-sorted DP and
CD4  and CD8  SP thymocytes, as well as CD4  and CD8 
mature T cells of normal C57BL/6 mice, were subjected to
semiquantitative RT-PCR analyses. We used total thymocytes
from Rag-2–deficient mice as DN cells. As shown in Fig. 6 D,
c-FLIP was expressed at a low level in DN cells and up-regu-
lated in DP cells. c-FLIP expression was detected at similar
levels in CD4  and CD8  SP thymocytes and peripheral ma-
ture T cells (Fig. 6 D). These data indicate that c-FLIP expres-
sion is developmentally regulated. Furthermore, the expression
pattern of c-FLIP in developing T lymphocytes is highly cor-
related with that of Fas expression (Fig. 6 C; reference 5).
Erk and NF- B signaling in c-FLIP /  SP thymocytes
Previous data showed that c-FLIP interacts with TRAF1,
TRAF2, RIP, and Raf-1 and promotes the activation of NF-
 B and Erk signaling pathways (25). To determine whether
c-FLIP is required for activation of these pathways, we first
tested Erk phosphorylation in purified c-FLIP /  CD4  SP
thymocytes stimulated with anti-CD3. The phosphoryla-
tion of Erk after anti-CD3 stimulation was comparable in
c-FLIP /  and control CD4  SP thymocytes (Fig. 7 A). We
also observed a similar pattern of Erk phosphorylation in
c-FLIP /  thymocytes stimulated with PMA plus ionomycin
(Fig. 7 B). To examine NK- B signaling, we tested I B 
degradation in CD4  SP thymocytes from c-FLIP /  and
control mice. I B  degradation in c-FLIP /  SP thymocytes
was comparable to that in control cells after stimulation by ei-
ther anti-CD3 or PMA plus ionomycin (Fig. 7 C). We also
measured Ca2  flux in c-FLIP /  CD4  SP thymocytes after
anti-CD3 and CD4 cross-linking. The overall Ca2  flux of
c-FLIP /  CD4  SP thymocytes was not obviously changed
except for a slight delay in the peak response (Fig. 7 D). Col-
lectively, these results demonstrate that the Erk and NF- B
signaling pathways in c-FLIP /  SP thymocytes are largely in-
tact and suggest that c-FLIP is not essential for the activation
of these pathways on TCR/CD3 stimulation.
DISCUSSION
By analyzing T lymphocyte development in c-FLIP condi-
tional KO mice, we have demonstrated that c-FLIP is essen-
tial for the efficient development of mature T lymphocytes.
The almost complete lack of mature T lymphocytes in the
LN and spleen of c-FLIP-deficient mice is because of im-
pairment at the SP stage in the thymus. Although CD4  and
CD8  mature T cells gradually accumulate in the spleen and
LN of 5-wk-old and older c-FLIP mutant mice, at least a
fraction of these cells are likely derived from the homeostatic
expansion of a few cells that escaped Lck-cre–mediated dele-
tion of c-FLIP in the thymus. These cells contain the floxed
c-FLIP allele. These results suggest a critical requirement for
c-FLIP in the maturation of conventional TCR    T lym-
phocytes. In addition, the reduced number of TCR   DN
T cells in the thymus of c-FLIP /  mice suggests that the
development of this T cell lineage also depends on c-FLIP.
In contrast, TCR   T cells differentiate normally in
c-FLIP /  mice. These results may be because of a differen-
tial requirement for c-FLIP in the development of these two
lineages. Alternatively, the floxed c-FLIP alleles may be dif-
ferentially deleted in these two subsets of T cells. Further-
more, our results do not rule out that c-FLIP may also be re-
quired for efficient development of DN thymocytes. The Lck
promoter–driven, Cre-mediated deletion of floxed genes starts
Figure 7. TCR-induced signaling in c-FLIP /  thymocytes. (A) Erk 
phosphorylation of CD4  SP thymocytes from c-FLIP /  and control mice 
after anti-CD3 stimulation. FACS-purified CD4  SP thymocytes were stimu-
lated with anti-CD3 and lysed for anti-pERK or -ERK blot analyses. (B) Erk 
phosphorylation of CD4  SP thymocytes from c-FLIP /  and control mice 
after stimulation with 10 ng/ml PMA plus 1  g/ml ionomycin. (C) I B  deg-
radation in c-FLIP /  CD4  SP thymocytes. Thymocytes were stimulated as in 
A and B. Loading controls are nonspecific bands that appeared on the same 
blot. (D) Ca2  flux in CD4  SP thymocytes from c-FLIP /  and control mice.C-FLIP IN MATURE T CELL DEVELOPMENT | Zhang and He 402
at the DN3 stage or later (28). Residual c-FLIP in develop-
ing thymocytes may be sufficient for DN cells to differenti-
ate into the DP stage. In fact, a severe defective DN3 to
DN4 transition was observed in c-FLIP / /Rag2 /  chi-
meric mice (see Chau et al. [29] on p. 405 of this issue), sug-
gesting that c-FLIP plays critical roles at multiple stages of
thymocyte development.
DP thymocytes in c-FLIP–deficient mice appear to be
normal by several criteria. First, DP thymocyte numbers in
c-FLIP /  mice are comparable to those in control mice.
Second, DP thymocytes in the mutant mice up-regulate sev-
eral surface markers, such as CD69 and CD5, at similar levels
to those of control thymocytes, suggesting normal positive
selection in these cells. Third, similar expression levels of
TCR/CD3 on CD4  and CD8  SP thymocytes are found
in c-FLIP /  and control mice, further suggesting normal
TCR   rearrangement and selection. In contrast, the num-
ber of CD4  and CD8  SP thymocytes in c-FLIP /  mice
is 50–70% lower than that of controls. Moreover, these cells
have not down-regulated one coreceptor, as well as CD24,
indicating that these cells have not completed the last steps of
maturation at the SP stage.
Our results suggest that the primary role of c-FLIP in
thymocyte maturation is to protect SP thymocytes from ap-
optosis. It is well established that Fas expression is up-regu-
lated at the DP stage and remains high at the SP stage (4–7).
FasL has also been detected on thymic stromal cells and a
fraction of thymocytes (8, 9). The expression pattern of Fas
and FasL in the thymus raises the question of why Fas does
not appear to induce large-scale thymocyte death in the nor-
mal thymus. Given the role of c-FLIP in inhibiting Fas-
induced caspase-8 activation in other types of cells (21),
c-FLIP is an attractive candidate to regulate thymocyte sen-
sitivity to Fas–FasL interaction in vivo. Several lines of evi-
dence support such a role for c-FLIP in thymocyte matura-
tion. First, c-FLIP is up-regulated in DP thymocytes and
expressed in CD4  and CD8  SP thymocytes, an almost
identical expression pattern as that of Fas (Fig. 6, C and D;
reference 5). Second, DP and SP thymocytes from c-FLIP / 
mice exhibit a dramatically enhanced sensitivity to Fas-
induced killing. Third, instead of being activated by TCR/
CD3 stimulation, CD4  SP thymocytes from c-FLIP / 
mice undergo rapid apoptosis on stimulation. This result also
supports a long-held notion that primary T cells are resistant
to activation-induced cell death caused by protection con-
ferred by c-FLIP (21). Fourth, freshly isolated CD4  and
CD8  SP thymocytes have higher apoptotic rates. It is im-
portant to note that c-FLIP /  thymocytes displayed higher
apoptosis rates in culture without stimulation. The increased
death might be caused by the loss of its inhibiting effect of
c-FLIP on caspase activation induced by in vitro culture. Al-
ternatively, c-FLIP /  thymocytes might have already re-
ceived death signals in vivo. In either case, the increased
“spontaneous” apoptosis in c-FLIP /  thymocytes seems
only to contribute partially to the increased TCR/CD3 and
Fas-induced apoptosis based on two pieces of our data. First,
 70–95% of c-FLIP /  SP thymocytes undergo apoptosis
after TCR/CD3 and Fas stimulation for 5 h, compared with
 50% spontaneous apoptosis (Figs. 5 and 6), suggesting a
further increase in cell death on these stimulations. Second,
no live cells were detected among CFSElow CD4  and
CD8  SP thymocytes from c-FLIP /  mice after TCR/
CD3 stimulation. This suggests that activated cells are more
prone to apoptosis than resting thymocytes (Fig. 4).
Why are CD4  and CD8  SP compartments in
c-FLIP /  mice selectively impaired even though DP thy-
mocytes also exhibit dramatically increased sensitivity to Fas-
induced killing in vitro? The answer to this may lie in the
expression pattern of FasL in the thymus. FasL expression is
detected in thymic epithelial cells and dendritic cells in the
medulla (8), a region to which thymocytes migrate after pos-
itive selection (2). The interaction of Fas-expressing SP thy-
mocytes with FasL-expressing thymic stromal elements in
this region may result in apoptosis of CD4  and CD8  thy-
mocytes if these cells are not protected by c-FLIP. Consis-
tent with this notion, freshly isolated CD4  and CD8  SP
thymocytes from c-FLIP /  mice exhibit a higher degree of
apoptosis than cells from control mice, suggesting that these
cells receive FasL signals in the medulla in vivo.
However, FasL is also detected in a fraction of cells of
each thymic subset (9). This observation raises an intriguing
question regarding the role of FasL expressed by thymocytes:
is thymocyte FasL able to trigger Fas by an autocrine man-
ner? FasL expression on thymocytes is extremely low (8, 9).
Low-level expression may mediate a positive signaling pro-
cess through its own cytoplasmic tail in thymocyte selection,
but it may not be sufficient to trigger Fas. In support of this,
enhanced expression of thymocyte FasL in a transgenic
model induced thymocyte apoptosis (30). Although we fa-
vor the view that the increased apoptosis of thymocytes in
c-FLIP /  mice is mediated by Fas–FasL interaction, other
death receptors may also be responsible for the enhanced ap-
optosis. Future analysis of c-FLIP /  mice in gld (FasL) or lpr
(Fas) mutant backgrounds will address this issue. Nonethe-
less, our results suggest that expression of c-FLIP in SP thy-
mocytes represents a key mechanism to ensure the comple-
tion of T cell maturation. Other mechanisms may also exist
to regulate the difference in sensitivity to Fas-induced killing
by normal DP and SP thymocytes.
Many studies have suggested the involvement of c-FLIP
in T lymphocyte activation and proliferation (24, 25, 31–
33). Transgenic expression of c-FLIPL in T cells results in in-
creased CD3-induced proliferation (24). Furthermore, over-
expression of c-FLIPL in Jurkat T cells promotes activation
of NF- B and Erk signaling pathways (25). However, sev-
eral other studies reported different effects on T cell activa-
tion by overexpressed c-FLIPL. In one report, retrovirally
introduced c-FLIPL did not have any effect on T lympho-
cyte proliferation (34). In another study, transgenic expres-
sion of c-FLIPL in T cells inhibits their CD3-induced prolif-
eration and activation of Erk and NF- B (31). In addition,
c-FLIPL has been reported to inhibit activation of p38 mito-JEM VOL. 202, August 1, 2005 403
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gen-activated protein kinase and NF- B in other cell types
(35–37). These contradictory results are likely caused by the
differences in the overexpression levels of c-FLIPL in each
system. Our results show that the phosphorylation of Erk
and activation of NF- B in c-FLIP /  thymocytes stimu-
lated through TCR/CD3 are largely intact. However, we
have observed certain degrees of defects, such as a delayed
peak of Ca2  flux in c-FLIP /  thymocytes after TCR/CD3
activation. Furthermore, our data show an almost complete
lack of activated and proliferating T cells, as well as reduced
production of IL-2 in c-FLIP /  thymocytes after TCR/
CD3 stimulation. This may likely be caused by rapid apop-
tosis of c-FLIP /  thymocytes on stimulation. However, in
light of the role of c-FLIP in mature T cell proliferation (see
Chau et al. [29] on p. 405 of this issue), both defective SP
thymocyte proliferation and rapid apoptosis may contribute
to the lack of proliferating T cells in c-FLIP /  SP thy-
mocytes stimulated by anti-CD3.
It is interesting to note that mice lacking caspase-8 ex-
hibit a similar defect in the mature T lymphocyte compart-
ment (38). Caspase-8 conditional KO mice have a dramati-
cally reduced number of CD4  and CD8  T cells in the LN
and spleen, whereas thymocyte development appears to be
normal. Although the caspase-8 gene is located in close prox-
imity to that of c-FLIP ( 40 kb), the defective mature T cell
development in c-FLIP /  mice is not caused by altered cas-
pase-8 expression (unpublished data). Furthermore, the de-
fective mature T cell compartment in caspase-8 conditional
KO mice may be caused by a role of caspase-8 in T cell ho-
meostatic proliferation.
Finally, it is important to point out that the impaired T
cell maturation in c-FLIP /  mice results from deletion of
both c-FLIPL and c-FLIPS. In contrast, most of the overex-
pression studies have only used c-FLIPL. Although it has
been shown that both c-FLIPL and c-FLIPS inhibit caspase-8
activation, these two isoforms do have different functions
(21). Our c-FLIP conditional mice will provide a good
model to dissect the in vivo role of these isoforms in T cell
development and activation.
MATERIALS AND METHODS
Generation of c-FLIP conditional KO mice. To generate c-FLIP
conditional KO mice, genomic fragments from a c-FLIP bacterial artificial
chromosome clone (RPCI) were cloned into the pGKneoF2L2DTA tar-
geting vector so that exon 1 of the c-FLIP gene was flanked by two loxP
sites. The targeting construct was linealized by NotI and transfected into the
TC1 ES cells (39). ES cell clones with homologous recombination were
identified by PCR and Southern blot. Three ES cell clones with the correct
targeting events were injected into C57BL/6 blastocysts. Chimeric male
founder mice (c-FLIPfl/ ) were crossed with the FLPeR female mice (pro-
vided by P. Soriano, Fred Hutchinson Cancer Research Center, Seattle,
WA; reference 40) to delete the neomycin cassette flanked by two FRT
sites. c-FLIPfl/  mice were bred with Lck-cre transgenic mice (The Jackson
Laboratory; reference 28) to generate c-FLIPfl/flLck-cre, c-FLIPfl/ Lck-cre,
and c-FLIPfl/fl mice. The phenotypes of c-FLIPfl/ Lck-cre mice are indistin-
guishable from those of wild-type C57BL/6   129 mice (c-FLIP / ).
These two types of mice were used as controls throughout the experiments.
Animal usage was conducted according to protocols approved by the Duke
University institutional animal care and use committee.
Flow cytometric analysis. Single-cell suspensions of the thymus, spleen,
and lymph nodes were lysed of RBCs, incubated with an FcR blocker
(2.4G2; eBioscience), followed by biotinylated mAb, PE-streptavidin, and
FITC-, CyChrome-, or APC-labeled mAb on ice for 30 min, and washed
with PBS containing 2% FCS. Data for 1–5   104 cells were collected on a
FACScan flow cytometer (BD Biosciences) and analyzed using CellQuest
(Becton Dickinson) software. All fluorescence-labeled antibodies, including
anti-CD3, -CD4, -CD5, -CD8, -CD24, -CD25, -CD69, -CD44, -CD62L,
-TCR  , -TCR  , and -Fas, were obtained from eBioscience, Biolegend,
or BD Biosciences. Apoptotic cells were determined by Annexin V and
7-AAD staining using an Annexin V–PE kit (BD Biosciences).
PCR and Southern blot analysis. PCR to determine the floxed and
wild-type c-FLIP alleles was performed at 93 C for 30 s, 56 C for 30 s, and
65 C for 90 s for 40 cycles. The primers for the wild-type and floxed
c-FLIP alleles were the same: forward, 5 -TAGCTGATGCATGAGCCT-
GAGC-3 ; reverse, 5 -GTACCAGAACTCTCCAGTCAT ACTTG-3 .
Southern blot analysis was performed as described previously (41).
Lymphocyte activation and Western blot assay. Total or purified
thymocytes were incubated with 10  g/ml anti-CD3 (2C11) on ice for 30
min, washed with ice-cold RPMI 1640 with 10% FBS, and cross-linked
with 75  g/ml rabbit anti–hamster IgG (Sigma-Aldrich) at 37 C for the time
indicated in the figures. Total cell lysates were generated after TCR stimula-
tion and subjected to Western blot assay. Anti–c-FLIP was from Qbiogene.
Anti-Erk and -Erkp were from Santa Cruz Biotechnology, Inc.
Cell proliferation assays. CFSE-labeled (Molecular Probes) thymocytes
were stimulated with plate-bound anti-CD3 (2C11; eBioscience) and/or
anti-CD28 (clone 37.51; BioLegend) for 3 d, and the proliferation was de-
termined by FACS analysis of CD4  or CD8  T cells.
Ca2  flux assay. 107 thymocytes were harvested and diluted in 1 ml of
loading buffer (10 mM Hepes, pH 7.5, and 1% FBS). Thymocytes were in-
cubated with 8  l Indo-1 mix, containing 0.25  g/ l Indo-1 (Molecular
Probes) and 2.5% Pluronic (Molecular Probes) in DMSO, and 65% FBS for
30 min at 30 C. Cells were washed, resuspended in loading buffer, and in-
cubated with PE-CD4 and FITC-CD8 for 15 min. 106 labeled cells were
resuspended in 500  l of loading buffer and incubated with 6  l biotin–
anti-CD3/biotin–anti-CD4 (5:1; 0.5 mg/ml each) for 1 min, then sub-
jected to FACS analysis. After 15 s, 12.5  l of 1 mg/ml streptavidin was
added to induce Ca2  flux, and the analysis was kept for another 5 min.
Fas- or TCR/CD3-induced apoptosis. Total or purified thymocytes,
as indicated in the figures, were incubated on plate-bound anti-Fas (clone
Jo2; BD Biosciences) or anti-CD3 (2C11) for the indicated times. Apop-
totic cells were determined by Annexin V and 7-AAD staining.
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